White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
In what the White House is calling a historic step to lower drug costs, President Donald Trump announced new agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to slash…